Certified by Founder
Lodge
Asimov
start up
United States
- Boston, Massachusetts
- 09/01/2023
- Series B
- $200,000,000
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
- Industry Biotechnology Research
- Website https://www.asimov.com/
- LinkedIn https://www.linkedin.com/company/asimov/
Cosmico | $12,000,000 | (May 19, 2026)
Hacktron AI | $2,900,000 | (May 19, 2026)
Shyld AI | $13,400,000 | (May 19, 2026)
Onramp (1) | $12,500,000 | (May 19, 2026)
Sprouts.ai | $9,000,000 | (May 19, 2026)
Transient.AI | Undisclosed Amount | (May 19, 2026)
Furientis | $5,000,000 | (May 19, 2026)
Cimento AI | $3,000,000 | (May 19, 2026)
Multiverse | $70,000,000 | (May 19, 2026)
Blink - Employee Experience Platform | $17,000,000 | (May 19, 2026)
Elliptic | $120,000,000 | (May 19, 2026)
Arkeus | $18,000,000 | (May 19, 2026)